Benefit-risk analysis: examples using quantitative methods.
Holden
William L
WL
Aventis Pharmaceuticals, Bridgewater, NJ, USA. William.Holden@aventis.com
Juhaeri
Juhaeri
J
Dai
Wanju
W
D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy; D005260:Female; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D018570:Risk Assessment / Q000379:methods*
D018501:Antirheumatic Agents